This paper reports results of hematoporphyrin derivative based on photodynamic therapy (PDT) of 24 lung cancer lesions in 21 patients that were followed at least three months. Three of 24 lesions exhibited complete remission and 20 of 24 lesions exhibited a response to PDT. Tumors in twenty of twent
Hematoporphyrin derivative and laser photodynamical reaction in the diagnosis and treatment of malignant tumors
โ Scribed by Shou-Zhong Song; Jun-Heng Li; Jin Zou; Ming-Yan Shu; Fu-Yun Zhao; Mao-Lin Jin; Zhong-He Guo
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 369 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
โฆ Synopsis
This paper reports the use of hematoporphyrin derivative (HpD) with laser activation in China for the diagnosis and treatment of various kinds of malignant neoplasms.
Fluorescence observation for diagnosis was performed for 170 tumors. One hundred and fifty-one (88.8%) fluoresced visably upon excitation with either argon or He-Cd laser light.
One hundred and thirty-nine malignant tumors in 136 patients were treated by this method. The percentage of all tumors responding to treatment was 80.6%. Partial to complete response were obtained in 51.1 % of the tumors treated.
The advantages and disadvantages of this method are discussed. It was found effective in treating various kinds of neoplasms located at different anatomical sites.
The penetrating depth of the laser is shallow. This limits its effect and application. A search for new photosensitizing drugs and an increase in the penetrating depth of laser irradiation are urgent goals for further development of this technique.
๐ SIMILAR VOLUMES
Reported are first experiences with Nd:YAG laser treatment of benign, semimalignant, and malignant skin tumors in 90 patients. Treated lesions included condylomata acuminata, basal cell carcinomas, solar keratosis, squamous cell carcinomas, and secondary malignant skin tumors. First clinical and his
ESPITE great advances in medicine, the re-D sults of treatment of malignant tumors remains unsatisfactory. Development of chemotherapy of inoperable malignant tumors is still in a beginning state. T h e high mortality rate resulting from secondary growth-recurrence and metastases-in patients having
Brain tumors in young children are often extremely difficult to diagnose on clinical grounds. Ultrasound is of proven efficacy in the diagnosis of intracranial hemorrhage,' cystic lesions of the brain,2 and congenital anomalies of the brain.3 In age groups in which a n acoustic window to the brain i